Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial

In This Article:

Leap Therapeutics (LPTX) said Wednesday that updated findings from its phase 2 trial indicate that s

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.